Women’s Health & OB/GYN News

The concept of delayed gratification has been ingrained in us throughout medical school and residency. This mentality can sometimes lead to explosive spending as an attending when one enjoys a significant salary boost.

Noting that practice varies widely across hospitals, an expert panel came to a consensus on the first quality indicators for the care of opioid-exposed infants.

Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.

The Council for Medical Specialty Societies, or CMSS, announced the launch of a new initiative that aims to reduce clinicians’ reliance on race in clinical decision-making and patient harms.

Obstetrics and gynecology residents, fellows and early-career faculty report experiencing significant challenges when it comes to childbearing and parental leave, according to survey results published in Clinical Obstetrics and Gynecology.

Fidelma Dunne, MD, PhD, FRCP, FRCPI, describes herself as a wife, mother, grandmother, sister and daughter who draws satisfaction from her family and from her career in endocrinology.

A possible genetic rationale for why women acquire more autoimmune diseases than men has been discovered, according to findings published recently in Cell.

Researchers find that while clinicians agree on diagnostic and treatment practices for pediatric vulvar and perianal lichen sclerosus, management techniques lack uniformity, according to a study.

Fezolinetant was associated with significant improvements in patient-reported vasomotor symptom frequency and menopause-specific quality of life, according to an analysis published in Menopause.

New survey results from the AMA illustrate the burden of prior authorization, with many physicians reporting that it leads to serious patient harms, delays care, reduces work productivity and more.